Feature | February 03, 2014 | Raissa Rocha

An Update on Breast Density and Cancer Screening

The dense breast discussion continues, with many factors to consider for breast imaging

dense breasts

The practice of breast imaging and screening in women at risk for breast cancer is evolving as new imaging modalities are incorporated and researchers continue to study the implications of dense breast tissue in patients. At the 2013 annual meeting of the Radiological Society of North America (RSNA) in Chicago, there were several sessions highlighting trials and studies that brought breast density and cancer detection to the forefront.

Understanding Breast Density

It has been established that dense breast tissue is associated with a higher rate of missed cancers, particularly early-stage cancers, due to the similarities in appearance on mammograms. Women with dense tissue are also said to have an elevated risk of developing cancer in the breast. In a special interest session at RSNA 2013, presenters reported on research that examined breast density and the risks for breast cancer it may pose to patients.1

According to presenter Jennifer A. Harvey, M.D., FACR, professor of radiology at University of Virginia, dense breast tissue can be common among women, but not all occurrences of dense breast tissue link directly to a high risk for cancer. Rather, the elevated risk potentially can vary by age, race, geography and other factors such as eating and smoking habits. With assessment of breast density and the risk for breast cancer becoming an international area for study, it is important for all parties involved to understand the relationship between density and cancer, said Harvey.

In the session, Harvey reported on collaborative research performed throughout the years that continues to dive into the subject of breast density. Mammographic studies, dating from the 1980s and performed around the United States and other countries, were assessed for breast density and cancer incidence. Some of the findings revealed the varied nature of breast density: It is known that breast density declines with age, but the risk for cancer does not necessarily correlate with the decrease and may remain the same throughout a woman’s lifespan. And while dense breast tissue is known to mask cancers on mammograms, breast density did not translate directly to higher risks of cancer for all women. For example, Asian women were found to have denser breasts but reported fewer cancer incidences, said Harvey.

Measuring Breast Density

Part of the mission to understand breast density is the drive to measure and monitor it. Martin Yaffe, Ph.D., professor of medical biophysics at the University of Toronto, spoke on methods of deriving breast density from a variety of imaging modalities, including mammography, digital tomosynthesis and ultrasound. In order to improve screening practices, providers should identify strategies for proper screening of both women with dense breast tissue and women with fatty breast tissue, Yaffe said. Two-dimensional assessment of breast density is more commonly performed with traditional mammography, but 3-D volumetric analysis is believed to offer a more accurate look at density. The focus in the radiology community now, said Yaffe, is to develop a new predictive model of which patients at high risk are more likely to have breast cancer.

Mammography is known to have lower sensitivity for high-risk patients because dense breast tissue can be mistaken for cancers on mammograms. Supplemental imaging is often recommended for those patients in need of further analysis. Identifying cancers at earlier stages improves patient outcomes, but for women with dense breasts, cancers are often not found until later when they are more metastatic. 

“No one is talking about replacing mammography at this time,” said Wendie Berg, M.D., Ph.D., FACR, professor of radiology at the University of Pittsburgh. But often the question becomes not whether to perform supplementing imaging, but which imaging modality to pursue for further screening.

In addition to traditional mammography, clinicians have the option of using contrast-enhanced spectral mammography (CESM), ultrasound (such as automated breast ultrasound or ABUS), digital tomosynthesis, molecular breast imaging (MBI), magnetic resonance imaging (MRI) and computed tomography (CT), among others, for imaging the breast. Some offer a more detailed look at irregular-shaped masses in the breast while other modalities provide more ease and comfort for patients. A recent KLAS brief, “3 Things You Need to Know About Breast Imaging,” reported that while mammography remains first in line for breast cancer screening, ultrasound and tomosynthesis are making strides, with 90 percent of providers surveyed indicating that they rely on ultrasound for breast imaging after mammography. The brief also reported that 87 percent of providers stated they had a positive ROI when using tomosynthesis products, even without receiving reimbursements.

One technique offered during RSNA 2013 as a possible option for assessment of density is a noninvasive optical tool developed for breast imaging. “Non-invasive Optical Assessment of Breast Density and Identification of High-risk Subjects,”2 presented by Paola Taroni, Ph.D., professor of physics at Politecnico di Milano in Milan, Italy, revealed that the optical mammography tool can provide functional and structural information on breast tissue through noninvasive means and with no ionizing radiation. Researchers in the Milan study compared women already identified from mammographic studies as BI-RADS categories 1 to 3 and as category 4. The team observed craniocaudal and oblique views of both breasts using multi-wavelength optical mammography, and found that amounts of water and collagen content observed optically increased by BI-RADS category. The observations were consistent with known differences in composition and microscopic structure between dense and fatty tissue, according to Taroni. She concluded that optical estimation of breast density is feasible enough for clinical practice and could provide effective assessment of breast density to complement other imaging modalities in screening practices.

Getting Patients to Understand

Breast density “inform” legislation efforts continues to grow in the United States, with many states working on bills and others already enacting laws to require providers to send breast density notification letters to patients. But sometimes, there is little written about what to do when letters are sent and patients are faced with the information that their dense breasts leave them at higher risk for cancer.

The subject of dense breast patients choosing to pursue supplemental imaging was highlighted at RSNA 2013 during the session “Patient Awareness of Breast Density and Interest in Supplemental Screening Tests for Women With Dense Breasts Among Women at a County Hospital Compared to Women at an Outpatient Radiology Clinic of an Academic Medical Center,”3 where presenters reported on a study that compared women who obtained mammograms in different geographic and hospital settings. In that study, a survey was given to 153 women at a county hospital before their screening appointments, asking whether they were aware of the breast density topic and whether they were interested or willing to pay for additional tests (such as ultrasound or CESM) if they had dense breasts. A similar survey was also conducted at an outpatient radiology clinic at an academic medical center. The study found that women who obtained screening at the county hospital were interested in their breast density, but less willing to incur expenses for additional imaging than women at the outpatient clinic.

“Patient awareness is worse in county hospital settings,” concluded Long Trinh, M.D., currently at Stanford University in Stanford, Calif. “We found that a majority of women were not willing or able to do supplementary imaging.” This is often explained by the fact that women who visit county hospitals for routine mammograms typically do not pursue more care than what is covered under insurance. Women from more rural backgrounds also face longer travel times if they choose to undergo supplemental imaging tests, said Trinh. The disparity shows that if breast density notification and supplemental imaging are to be successful, providers and insurance companies need to ensure that the correct information is communicated and that patients in need of additional screening can afford it.  

References

1. Berg W M.D., Ph.D., Harvey J M.D., Yaffe M Ph.D, Smith, R Ph.D,
“Special Interest Session: Breast Density: Risk Assessment,
Communication, and Approaches to Supplemental Imaging,” session presented at RSNA 2013.

2. Taroni, P Ph.D., “Non-invasive Optical Assessment of Breast Density and Identification of High-risk Subjects,” session presented at RSNA 2013.

3. Trinh L M.D. et al, “Patient Awareness of Breast Density and Interest in Supplemental Screening Tests for Women with Dense Breasts among Women at a County Hospital Compared to Women at an Outpatient Radiology Clinic of an Academic Medical Center,” session presented at RSNA 2013.

Related Content

Clinical Trial Testing Topical Gel to Reduce Breast Density
News | Breast Density | June 19, 2018
Women with dense breast tissue soon might be adding a new product to their skincare routine to help them fight breast...
California Women In Favor of Extending State's Breast Density Inform Law
News | Breast Density | June 15, 2018
A recent survey of California women found that 95 percent of respondents want the state’s breast density inform law to...
Women More Likely to Use Other Preventive Health Services Following Mammography
News | Mammography | June 13, 2018
Medicare beneficiaries who undergo breast cancer screening with mammography are more likely than unscreened women to...
How AI and Deep Learning Will Enable Cancer Diagnosis Via Ultrasound

The red outline shows the manually segmented boundary of a carcinoma, while the deep learning-predicted boundaries are shown in blue, green and cyan. Copyright 2018 Kumar et al. under Creative Commons Attribution License.

News | Ultrasound Imaging | June 12, 2018 | Tony Kontzer
June 12, 2018 — Viksit Kumar didn’t know his mother had...
Breast imaging technologies have seen a rapid evolution.

Breast imaging technologies have seen a rapid evolution.

Feature | Women's Health | June 05, 2018 | By Jeff Zagoudis
Breast imaging technologies have evolved rapidly in the last two decades to help physicians detect breast cancers at
Breast Cancer Survivors Not Getting Recommended Number of Mammograms Post-Surgery
News | Mammography | May 24, 2018
Breast cancer survivors are not getting the recommended level of screening post-surgery, according to a newly-published...
Breast Cancer Places Greater Financial Burden on Black Women
News | Women's Health | May 16, 2018
Having breast cancer placed a significantly greater financial strain on black women than white women, according to a...
FDA's MQSA Accreditation Bodies Approved for Tomosynthesis Accreditation

Image courtesy of Fujifilm.

Feature | Mammography | May 14, 2018
On April 9, 2018, the U.S. Food and Drug Administration (FDA) announced that all four of its Mammography Quality...
Overlay Init